Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE (0.4%), DAX (0.5%), CAC (0.8%)

Oct 22 ,2026

  • Synopsis

    • European equity markets are set to open broadly lower, tracking weaker Asian markets. Losses picking up in South Korea and Japan. Greater China under pressure with Hang Seng tech gauge down to lowest since Sep-2024. S&P 500 futures lower afterhours. Crude strengthening following reports US, Israel have readied Iran attack plans. No uplift for Asian memory producers from overnight AI bounce. Trading turned more cautious after US market close with Nasdaq futures weighed down by TSLA and the negative spin surrounding its capex downgrade. Other US tech reported after market close, META revenue topped estimates with Q4 guidance midpoint also above consensus. Touted Muse success with focus now on scaling it up. Lifted lower end of 2026 capex guidance range. Confirmed establishment of non-voting shares, amounting to 2:1 stock split, with funds earmarked for acquisitions and AI expansion. Neocloud sentiment a bit better with Elice (015850.KS) extending Wednesday's rally (stock now up 60% from opening day low). China AI model developers and tech platforms under pressure. Bloomberg sources noted DeepSeek raised ~CNY100B in latest funding round, higher than CNY50-80B it targeted. In macro developments, BOK left interest rates unchanged as widely expected in a unanimous decision. Maintained hawkish bias with board to decide on timing and pace of future increases.

    • Busy session for earnings/updates in Europe. SAP (SAP.GR) delivered a strong Q3, beating on EPS, reported Current cloud backlog of €24.1B, up 26% at constant currencies, and raising its 2026 cloud & software revenue growth target, while Roche (ROP.SW) topped revenue expectations and confirmed full-year guidance. Nestlé (NESN.SW) also beat on organic sales growth of +4.0% vs consensus +3.4%, reaffirming guidance. UCB (UCB.BB) was a standout, dramatically raising its FY adjusted EBITDA growth guidance to low-to-mid forties from mid-teens previously. Galderma (GALD.SW) impressed with a significant Q3 revenue beat and raised FY guidance, while Nokia (NOKIA.FH) beat on EPS and Essity (ESSITY.B.SS) delivered a clean earnings beat. Today's other key reporters include Barclays (BARC.LN), UniCredit (UCG.IM), Atlas Copco (ATCO.A.SS), Sandvik (SAND.SS), VINCI (DG.FP), L'Oréal (OR.FP), Hermès (RMS.FP) and LSEG (LSEG.LN).

    • In M&A, Qiagen (QGEN) confirmed its acquisition by EQT at €46.60/share, and CVC is reportedly circling Verisure (VSURE.SS).

    • Notable broker calls include Maersk (MAERSK.B.DC) cut to Sell at Goldman Sachs, Commerzbank (CBK.GR) downgraded at Barclays, and EssilorLuxottica (EL.FP) upgraded to Buy at Deutsche Bank.

    • European macro data releases include France Oct business confidence, Eurozone Oct flash consumer confidence, UK Oct industrial trends orders - CBI, Norway Sep unemployment rate, Ireland Sep PPI

    • In central banks, Kåkånomics economics festival (Wed-Thu) sees Norges Bank's Moen panellist at 10:15 and Bache interviewed at 17:00. Austria central bank's Kocher speech at 11:30CET at Gewinn Messe (Thu-Fri, also company execs and politicians speaking). Ireland central bank's McMunn speech at 10:40BST at European Insurance Forum. Bundesbank's Köhler-Geib panellist at 13:45CET at Berlin Global Dialogue 2026. Riksbank's Jansson discusses monetary policy at 15:00CET at the National Mediation Office's conf on the macroeconomic conditions for wage formation. Italy central bank's Panetta in conversation at 16:15CET at the International Festival of Economics in Turin. Bank of Spain's Escrivá and Bank of Portugal's Pereira opening remarks/panellists at 17:00CET at seminar on Iberian Economic Integration (livestream). BOE's Braddick speech at 21:00BST at Mansion House, City Regulators Dinner. Slovakia central bank's 'Capital Market 2026' seminar. WE_ARE_IN Macroeconomics and Finance Conf (through Fri). Türkiye central banks interest rate decision at 13:00CET. No change expected in 37.0% benchmark interest rate. SNB minutes on last MPC meeting released at 9:30CET. Ireland central bank's O'Keeffe speech at Blockchain Ireland Summit.

    • Chancellor Merz will travel to Montenegro, to participate in the annual summit of the Berlin Process, and will meet with representatives of the Western Balkan states and European partners. EU leaders, including EU's von der Leyen and Costa to meet with Vietnam's To Lam in Brussels. EU Informal meeting of trade ministers (through Fri), participants include EU's Šefčovič. Conference of the heads of government of the German States. In the UK, there are MPs questions on environment, food and rural affairs whilst committee topics include clean power by 2030: Upgrading the grid at 10:00. EU's Albuquerque opening address virtually at the Nordic Financial Unions (NFU) Conf. Moody's Banking Conf - UK, speakers include HSBC Holdings (HSBA.LN) CFO at 10:15BST, BOE's David Bailey 11:50. Annual Conf. of the Forum for Macroeconomics and Macroeconomic Policies (FMM) of the Hans Böckler Foundation.

  • Politics/Macro/World News

    • Consumer confidence tumbles ahead of Budget - ES

  • Top company news

    • Earnings/updates

      • DACH

        • SAP.GR (SAP) -- reports Q3 non-IFRS EPS €1.89 vs FactSet €1.81 [16 est, €1.70-1.96]; Current cloud backlog of €24.1B, up 28% and up 26% at constant currencies; raised 2026 cloud & software revenue growth target and reiterated view of revenue growth acceleration in 2027

        • ROP.SW (Roche Holding) -- reports Q3 revenue CHF16.13B vs consensus CHF15.75B; confirms FY guidance

        • QGEN (Qiagen) -- confirms business combination agreement with Crown NL Bidco (EQT) at €46.60/sh

        • QGEN (Qiagen) -- reports preliminary Q3 EPS $0.65 ex-items vs FactSet $0.62 [11 est, $0.61-0.64]

        • NESN.SW (Nestle) -- reports Q3 revenue CHF22.76B vs consensus CHF22.49B; Organic Sales Growth +4.0% vs consensus +3.4%; reaffirms FY guidance

        • KNIN.SW (Kuehne & Nagel) -- reports Q3 EPS CHF2.57 vs consensus CHF2.37; raises FY26 EBIT guidance range mid-point by CHF 100M (

        • GALD.SW (Galderma Group) -- reports Q3 revenue $1.63B vs FactSet $1.54B [4 est, $1.53-1.56B]; raises FY net sales growth guidance to +22.5-23.5% at constant currency, from +19-21% previously

        • SCHP.SW (Schindler Holding) -- reports Q3 EPS CHF2.81 vs consensus CHF2.58; raises FY EBIT reported margin guidance

        • R3NK.GR (Renk Group) -- enters binding agreement to sell slide bearings business to Miba AG, terms not disclosed; revises guidance

        • SRT3.GR (Sartorius) -- reports Q3 underlying EBITDA €279.9M vs consensus €268.9M; FY26 guidance confirmed and partially refined

        • FTK.GR (flatexDEGIRO) -- reports Q3 net income €50.3M vs FactSet €50.6M [3 est, €49.1-51.7M]; intends to launch share buyback program of up to €100M

        • EMSN.SW (EMS-Chemie Holding) -- reports 9M revenue CHF1.51B vs year-ago CHF1.49B

        • GALE.SW (Galenica) -- reports 9M revenue CHF3.17B, +6% vs year-ago CHF3.00B; reaffirms FY outlook

        • VOS.GR (Vossloh) -- reports Q3 net income €9.4M vs FactSet €14.1M [1 est]

      • Nordics

        • NOKIA.FH (Nokia) -- reports Q3 comparable EPS €0.09 vs consensus €0.06; FY26 outlook unchanged

        • SEB.A.SS (Skandinaviska Enskilda Banken) -- reports Q3 EPS SEK3.81 vs consensus SEK4.00

        • SWED.A.SS (Swedbank) -- reports Q3 net income SEK8.25B vs consensus SEK8.14B (SEK 394.50)

        • TELIA.SS (Telia) -- reports Q3 EPS SEK0.69 vs consensus SEK0.65; raises FY Adjusted EBITDA growth LFL to +3-4% vs prior guidance around +3% (

        • SAVE.SS Nordnet reports Q3 EPS SEK3.50 vs FactSet SEK3.58 [11 est, SEK3.33-3.72]

        • ESSITY.B.SS (Essity) -- reports Q3 adj EPS SEK4.92 vs FactSet SEK4.36 [10 est, SEK3.80-4.94]; strategic review of Consumer Tissue is proceeding according to plan

        • SCATC.NO (Scatec) -- lowers FY 2026 power production EBITDA estimate

        • PNDX.B.SS (Pandox) -- reports Q3 cash EPS SEK4.14 vs FactSet SEK3.91 [5 est, SEK3.67-4.10]

        • BILL.SS (Billerud ) --reports Q3 EPS SEK0.85 vs FactSet SEK0.61 [9 est, SEK0.50-0.79]

      • Southern Europe

        • MONC.IM (Moncler) -- reports Q3 revenue €605.5M vs consensus €596.8M

        • PUIG.SM (Puig Brands) -- reports Q3 revenue €1.39B vs StreetAccount €1.37B; reaffirms FY 2026 outlook

      • Benelux

        • BESI.NA (BE Semiconductor Industries) -- reports Q3 EPS €1.33 vs StreetAccount €1.28

        • AZE.BB (Azelis Group) -- reports Q3 adjusted EBITA €114M vs FactSet €114.7M

        • UCB.BB (UCB) -- raises FY adj. EBITDA growth guidance to low- to mid-forties range from mid-teens to low-twenties range at constant exchange rates

      • France

        • IPN.FP (Ipsen) -- reports Q3 revenue €1.17B vs StreetAccount €1.13B: Upgrades its financial guidance for 2026

        • NEX.FP Nexans reports Q3 revenue €1.70B vs StreetAccount €1.40B

        • HO.FP (Thales) -- reports 9M revenue €16.42B vs consensus €16.33B; Orders €19.12B vs consensus €18.58B

        • FDJU.FP (La Francaise des Jeux) -- reports Q3 revenue €794M, (8%) vs year-ago €864M

        • COV.FP (Covivio) -- reports 9M revenue €803.7M, +51% vs year-ago €533.0M

        • FNAC.FP (Fnac Darty) -- reports Q3 revenue €2.50B vs year-ago €2.49B

        • LOCAL.FP (Solocal Group) -- reports Q3 revenue €76.1M vs FactSet €76.6M [1 est]

        • IDL.FP (ID Logistics Group) -- reports Q3 revenue €1.18B vs FactSet €1.09B [1 est]

      • PROT.NO (Protector Forsikring) -- reports Q3 net income NOK853M, +82% vs year-ago NOK468M

      • Also reporting today

        • Finland: Metso Corp. (METSO.FH), Fiskars (FSKRS.FH), OLVI (OLVAS.FH), Lindex Group (LINDEX.FH), Viking Line (VIK1V.FH), Atria (ATRAV.FH), Verkkokauppa.com (VERK.FH), SRV Group (SRV1V.FH) France: VINCI (DG.FP), Sartorius Stedim Biotech (DIM.FP), Groupe Guillin (ALGIL.FP) Norway: Yara International (YAR.NO), Nordic Semiconductor (NOD.NO), TGS-NOPEC Geophysical Co. (TGS.NO), Kitron (KIT.NO), Atea (ATEA.NO), Norske Skog (NSKOG.NO), Kongsberg Automotive (KOA.NO), Komplett (KOMPL.NO) Other: Icelandair Group (ICEAIR.IR) Southern Europe: Unicredit (UCG.IM), The Navigator Co. (NVG.PL), Bankinter (BKT.SM), Viscofan (VIS.SM), ATRESMEDIA (A3M.SM) Sweden: Atlas Copco (ATCO.A.SS), Sandvik (SAND.SS), Addtech (ADDT.B.SS), Beijer Ref (BEIJ.B.SS), Castellum (CAST.SS), Mycronic (MYCR.SS), Sagax (SAGA.B.SS), Axfood (AXFO.SS), Holmen (HOLM.B.SS), Thule Group (THULE.SS), Gränges (GRNG.SS), Vimian Group (VIMIAN.SS), Intea Fastigheter (INTEA.B.SS), BONESUPPORT HOLDING (BONEX.SS), Norion Bank (NORION.SS), Vitrolife (VITR.SS), Betsson (BETS.B.SS), AFRY (AFRY.SS), MilDef Group (MILDEF.SS), Hexatronic Group (HTRO.SS), Xvivo Perfusion (XVIVO.SS), Fastpartner (FPAR.A.SS), Dometic Group (DOM.SS), Hemnet Group (HEM.SS), Arjo (ARJO.B.SS), Logistea (LOGI.B.SS), Coor Service Management Holding (COOR.SS), Eastnine (EAST.SS), Linc (LINC.SS), Proact IT Group (PACT.SS), Humana (HUM.SS), Svedbergs Group (SVED.B.SS), Bonava (BONAV.B.SS), Midsona (MSON.B.SS), PowerCell Sweden (PCELL.SS), Enea (ENEA.SS), C-RAD (CRAD.B.SS), Nelly Group (NELLY.SS), Sedana Medical (SEDANA.SS), Ework Group (EWRK.SS), Rottneros (RROS.SS), Pricer (PRIC.B.SS), CDON (CDON.SS), Bactiguard Holding (BACTI.B.SS), Orexo (ORX.SS), Tobii (TOBII.SS), Alligator Bioscience (ATORX.SS), Viaplay Group (VPLAY.A.SS) UK: Barclays (BARC.LN), J Sainsbury (SBRY.LN), Auction Technology Group (ATG.LN), Bloomsbury Publishing (BMY.LN)

          Trading Update: Belgium: Kinepolis Group (KIN.BB) DACHs: Bystronic (BYS.SW) France: L'Oreal (OR.FP), Hermes (RMS.FP), VINCI (DG.FP), Unibail-Rodamco-Westfield (URW.FP), Rexel (RXL.FP), Aeroport de Paris (ADP.FP), Accor (AC.FP), Getlink (GET.FP), Wendel (MF.FP), Valeo (FR.FP), SEB (SK.FP), Tikehau Capital (TKO.FP), Lisi (FII.FP), Stef (STF.FP), Maurel et Prom (MAU.FP), Pierre & Vacances (VAC.FP), Voltalia (VLTSA.FP), SMCP (SMCP.FP), Nexity (NXI.FP), Roche Bobois (RBO.FP), Cegedim (ALCGM.FP), ATEME (ATEME.FP), SRP Groupe (SRP.FP), Guerbet (GBT.FP) Netherlands: Aalberts (AALB.NA), ACOMO (ACOMO.NA) Nordics: BioGaia (BIOG.B.SS) Other: Kerry Group (KRZ.ID) UK: RELX (REL.LN), London Stock Exchange Group (LSEG.LN), InterContinental Hotels Group (IHG.LN), Rentokil Initial (RTO.LN), Pearson (PSON.LN), Renishaw (RSW.LN), Inchcape (INCH.LN), AJ Bell (AJB.LN), Rathbones Group (RAT.LN), Hunting (HTG.LN), Foxtons Group (FOXT.LN)

    • M&A

      • QGEN (Qiagen) -- EQT close to deal to acquire Qiagen for €46.50/sh or €9.6B -- Bloomberg

      • QGEN (Qiagen) -- confirms business combination agreement with Crown NL Bidco (EQT) at €46.60/sh

      • VSURE.SS (Verisure Plc) -- CVC explores bid for Verisure Plc - FT

      • LSEG.LN (London Stock Exchange Group) -- could announce deal to acquire Octus from Permira as soon as Thursday (22-Oct) - FT, citing people familiar with the matter

      • FGR.FP (Eiffage) -- signs MoU with LOSC regarding proposed disposal of companies in charge of management of Decathlon Arena - Stade Pierre-Mauroy and its ancillary areas

      • R3NK.GR (Renk Group) -- enters binding agreement to sell slide bearings business to Miba AG, terms not disclosed; revises guidance

      • PNDX.B.SS (Pandox) -- divests seven hotel properties in Denmark and Sweden for SEK2.10B

      • Apollo and Blackstone seeking approval to acquire stakes in NFL teams - Bloomberg

      • Thoma Bravo revives effort to sell J.D. Power amid improving M&A environment - Bloomberg (earlier today)

      • Axel Springer explored buying TikTok's European arm - FT

    • Healthcare

      • AZN.LN (AstraZeneca) -- Ultomiris (ravulizumab) approved in US to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression

      • FME.GR (Fresenius Medical Care) -- announced the U.S. launch of the multiFiltratePRO System for critically ill patients with acute kidney injury

      • NWRN.SW (Newron Pharmaceuticals) -- completes enrollment of pivotal Phase 3 ENIGMA-TRS 1 study

    • Other

      • SY1.GR (Symrise) -- presents new clinical evidence for skin and digestive health at SupplySide Global 2026

      • SEB.A.SS (Skandinaviska Enskilda Banken) -- completes SEK1.25B share buyback program; decides to pause share buybacks

      • IVG.IM (Iveco Group) -- appoints Damiano Cretarola as CFO effective 2-Nov-26

      • HUSQ.B.SS (Husqvarna) -- provides update in EU's robotic mower anti-dumping investigation

      • CO.FP (Casino Guichard-Perrachon) -- Plesio and the Normandy-Picardy Cooperators to build partnership under the Casino brand

      • NEL.NO (NEL ASA) -- appoints Morten Holum as CEO; to assume role no later than 1-May-27

      • European Automobile Manufacturers' Association (ACEA) September new car registrations for EU + EFTA + UK +10.2% y/y

  • Key rating changes

    • Upgrades

      • JPMorgan upgrades AGS.BB, ASRNL.NA; downgrades AGN.NA

      • EL.FP (EssilorLuxottica) -- to buy from hold at Deutsche Bank

      • GETI.B.SS (Getinge) -- to buy from hold at Handelsbanken

      • RS1.LN (RS Group plc) -- RS Group upgraded to buy from hold at Berenberg

      • XPP.LN (XP Power) -- to buy from hold at Deutsche Bank

    • Downgrades

      • UBI.FP (Ubisoft Entertainment) -- to underperform from neutral at BNP Paribas Exane

      • EBS.AV (Erste Group Bank) -- to market perform from outperform at Keefe, Bruyette & Woods

      • CA.FP (Carrefour) -- to neutral from buy at UBS

      • CBK.GR (Commerzbank) -- to equal weight from overweight at Barclays

      • HUSQ.B.SS (Husqvarna) -- to hold from buy at Danske Bank

      • OPM.FP (OPmobility) -- to neutral from overweight at JPMorgan

      • ALIF.B.SS (AddLife) -- to hold from buy at DNB Carnegie

      • DFS.LN (DFS Furniture) -- to hold from buy at Jefferies

      • KESKOB.FH (Kesko) -- to hold from buy at ABG Sundal Collier

      • MAERSK.B.DC (Maersk) -- to sell from neutral at Goldman Sachs

      • AGN.NA (Aegon) -- to neutral from overweight at JPMorgan

    • Other

      • STR.AV (STRABAG SE) -- reinitiated buy at Kepler Cheuvreux

  • Data

    • Nikkei (2.52%) to 62995.91

    • Hang Seng (3.18%) to 22900.67

    • Shanghai Composite (1.59%) to 3653.93

    • S&P futures (67.3) vs prior close of 7800.3

    • €-$ +0.0020 or +0.18% to 1.1253

    • $-¥ (0.81) or (0.51%) to 157.33

    • €-¥ (0.64) or (0.36%) to 176.99

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.